SEATTLE, July 3, 2013 – Greg Foltz, M.D., director of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute (Ivy Center), passed away from Stage IV pancreatic cancer on Thursday, June 27. Dr. Foltz, who was 50 years old, spent the last 20 years as a pioneer and champion for advancing brain cancer research in the hope of one day finding a cure.
Many of my patients are men seeking prostate cancer treatment they can undergo while continuing work and maintaining active lifestyles. Equally important is the cancer-free survival rate and long-term side effect profile. For over seven years we have been treating men with organ-confined prostate cancer using the CyberKnife® stereotactic radiosurgery system. This sophisticated radiation delivery system uses a robotic arm to deliver precise treatment doses to the prostate in only 5 sessions so the men can keep up their normal routine while combatting their disease.
The data supporting this treatment option continues to grow and a recent study following men for 6 years reports patients had excellent biochemical control rates (based on...
Thrive Through Cancer is a non-profit organization that helps young adults with cancer and their caregivers find hope and thrive. Through support groups, social events and community forums, Thrive Through Cancer aims to engage young adult community members by providing support and resources during their fight against cancer.
On June 20, 2013 Thrive Through Cancer will host a social event for young adults, their families, friends and caregivers at the Swedish Cancer Institute: Chemo-Con!
Come meet Rose Egge, founder of Thrive Through Cancer, and join us for two educational and interactive workshops focused on issues commonly experienced by young adults affected by cancer.
- Join Registered Dietician Julie Herbst for a conversation about healthy eating, maximizing nutritional intake and managing symptoms with foods. Recipe and sampling provided.
- Jacci Thompson-Dodd, MA, MSSS will host a discussion about intimacy and cancer, and can help answer any questions you may have.
You will also have the opportunity to learn more about community partners, resources and services available in areas near you from the following organizations:
Swedish Celebrates Dr. Saul Rivkin’s Long, Impressive Career as a Devoted, Accomplished Medical Oncologist and Researcher in Fight Against Ovarian Cancer
SEATTLE, June 6, 2013 – Swedish Cancer Institute (SCI) announced today that Saul Rivkin, M.D., medical oncologist, as well as founder and board chair of the Marsha Rivkin Center for Ovarian Cancer Research, will retire from his clinical practice at SCI on July 1, 2013. The highly respected and revered physician, who is 77 years old and has five daughters and seven grandchildren, Dr. Rivkin is best known for his committed, tenacious approach to fighting cancer and the personal connection he has established with the thousands of patients he has cared for over the years.
In today’s New York Times, actress and director Angelina Jolie bravely and openly discusses her experience with BRCA genetic testing for hereditary breast and ovarian cancer:
The 37 year old Ms. Jolie – who has not had cancer – underwent genetic testing because of her family history of cancer. She was found to carry a mutation in the BRCA1 gene, which puts her at significant risk of developing breast and ovarian cancers. Ms. Jolie, the mother of 3 adopted and 3 biological children, elected to undergo a risk-reducing double mastectomy, and plans to have her ovaries and fallopian tubes removed soon to lower her risk of developing ovarian cancer.
Ms. Jolie’s story opens a public conversation about the importance of genetic testing in helping to reduce a woman’s risk of developing breast and ovarian cancers. This very personal decision about mastectomy by someone widely regarded as one of the most beautiful women in the movies also helps women recognize that their body image and sexuality does not have to be defined by their breasts. Not every woman will make the decision to have major surgery, but genetic test results can also make sure that your breast cancer screening is appropriate for your level of risk; women who carry a BRCA gene mutation need ...
Going through cancer treatment as a patient, family member or caregiver can take a lot of personal time. And we know that being in a hospital environment on a day-to-day basis can be exhausting. Here at the Swedish Cancer Institute (SCI), we aim to provide resources and access to services to help your mind, body and spirit heal.
One way we do this is through using innovative programs that help connect patients and family members to resources within the community. Recently, SCI has launched a new iPad Loan Program that puts interactive and educational resources right at your fingertips.
You can use the iPads while waiting in the lobby or even during treatment to:
Misconceptions & Misunderstandings About Genetic Testing For Hereditary Cancer: My family history of cancer almost guarantees that one day I will develop cancer
Many people who have a family history of cancer often assume that they are at high risk of developing cancer and do not see the value of genetic counseling and genetic testing. The reasoning often goes like this:
“My mother, my cousin, and my grandmother all had breast cancer. I know there is a very high chance that I will develop it too. I would never have a mastectomy, so I am extra good about getting mammograms and my doctor checks my breasts every time I see her. I have a healthy diet, exercise regularly, rarely drink alcohol, and I have never put a cigarette to my lips. Since I am already doing everything I can possibly do, I don’t see how genetic counseling and genetic testing can help me.”
Of course, it is a good idea to be conscientious about your medical care, and everyone should maintain a healthy lifestyle, regardless of family history. The questions that genetic testing may answer for you are: